Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Your search for ���������������������������������:kn39��������� ������ ������ ������ returned no results
Showing 691 to 705 of 728 results for ���������������������������������:know��������� ������ ������ ������

  1. People with a rare form of blood cancer are set to benefit after NICE recommends new targeted therapy

    Hundreds of people with multiple myeloma could receive a new, targeted treatment recommended for use within the Cancer Drugs Fund today (Tuesday, 29 October).

  2. New Alzheimer's treatment donanemab does not currently demonstrate value for the NHS says NICE

    More evidence is needed on the clinical and cost-effectiveness of donanemab, a new treatment for mild Alzheimer’s disease.

  3. Healthcare professionals advised to ask people about gambling at health checks and GP appointments

    The recommendation is included in our first clinical guideline on gambling-related harms: identification, assessment and management.

  4. International collaboration provides new guidance on the use of surrogate endpoints in cost-effectiveness analysis

    Recommendations will help organisations that evaluate new drugs establish whether their use will result in longer-term benefits for patients

  5. Keep the size of your waist to less than half of your height, NICE recommends

    People are being encouraged to keep their waist measurement to less than half their height to reduce the risk of potential health problems.

  6. People who have had a stroke should be offered additional rehabilitation

    People who have had a stroke and who have continuing impairment or limitations on their activities should be offered additional rehabilitation to help them recover

  7. Evidence Evusheld is effective in protecting vulnerable adults against variants lacking, as NICE announces new rapid update process for COVID-19 medicines

    NICE issues draft guidance for public consultation which does not recommend Evusheld for preventing COVID-19 in some adults.

  8. NICE partners with international health technology assessment bodies

    Six health technology assessment (HTA) bodies from three continents are to collaborate on a range of topics that will benefit people accessing healthcare around the world.

  9. Updated guideline recommends more treatment choices for menopause symptoms

    New evidence shows that cognitive behavioural therapy (CBT) can help reduce menopause symptoms including hot flushes and night sweats, depressive symptoms and problems sleeping NICE has said in its draft updated guideline on menopause published today (17 November 2023).

  10. More people could be offered genetic testing for genes linked to ovarian cancer

    A new draft NICE guideline for inherited ovarian cancer published today (15 September 2023), recommends more people are tested for genes linked to ovarian cancer.

  11. Targeted treatment for rare form of aggressive lung cancer gets NICE approval

    Mobocertinib recommended as a treatment for a rare and aggressive form of lung cancer

  12. New life-extending treatment for rare forms of advanced gastroesophageal cancer

    Around 3,000 people could be eligible for a new life-extending combination therapy to treat rare forms of gastroesophageal cancer after NICE published final draft guidance today (24 November 2022).

  13. Nine treatment options to be made available for adults with depression or an anxiety disorder

    Six digitally enabled therapies for adults with anxiety disorders and three for adults with depression have been recommended for use in the NHS.

  14. Two new personalised immunotherapy treatments for aggressive forms of blood cancer recommended for the Cancer Drugs Fund

    NICE recommends two CAR-T therapies, both given as one-off infusions, to treat aggressive forms of blood cancer.

  15. Tackling health inequalities in children and young people

    We've updated our health inequalities web resource so that it maps NICE guidance to frameworks for children and young people.